Pharm-D Health Science 旗下益生菌品牌 Lang Bragman 荣登《大马纪录大全》获认为 “本地最大规模益生菌产品系列”

吉隆坡讯(2025年12月10日)— 医药健康产业集团 Pharm-D Health Science Sdn Bhd 旗下的益生菌品牌 Lang Bragman Probiotic Series 如今荣登《大马纪录大全》(Malaysia Book of Records),获得 “本地最大规模益生菌产品系列” 的认证。 Image 1: 大马医药健康产业集团Pharm-D Health Science 旗下的 Lang Bragman 益生菌系列,以科学为基础、涵盖多种健康需求、多元化益生菌配方而闻名。 以科学、安全与创新为核心, Lang Bragman 品牌拥有超过 34款益生菌产品,涵盖多方面的健康状况。所有产品均于符合 GMP 及 清真(Halal)标准的生产设施中制造,确保品质稳定与功效可靠。 如今,Lang Bragman 产品已于马来西亚及新加坡超过 800家药房与医疗中心上市销售,包括 BIG CARiNG集团旗下的 大西药房(BIG Pharmacy)、康宁药剂 (CARiNG Pharmacy)、巧治西药房 (Georgetown Pharmacy)、陈氏药剂行(Ting Pharmacy) 和 为您西药房 (Wellings Pharmacy) 等健康商城。 Pharm-D Health…

Lang Bragman, Jenama Probiotik Pharm-D Health Science, Diiktiraf Sebagai “Rangkaian Produk Probiotik Tempatan Terbesar” oleh Malaysia Book of Records

KUALA LUMPUR, 10 Disember 2025 – Lang Bragman sebuah jenama probiotik oleh Pharm-D Health Science Sdn Bhd telah diiktiraf sebagai “RANGKAIAN PRODUK PROBIOTIK TEMPATAN TERBESAR” (Largest Probiotic Series) oleh Malaysia Book of Records. Pengiktirafan ini diberikan kepada Pharm-D Health Science atas rangkaian produk probiotik yang merangkumi lebih daripada 34 formulasi untuk memenuhi pelbagai keperluan kesihatan.…

Pharm-D Health Science’s Lang Bragman Clinches Malaysia Book of Records for Largest Probiotics Range

Kuala Lumpur, Malaysia [10 Dec 2025] – Lang Bragman Probiotic Series by Pharm-D Health Science Sdn Bhd has been recognised by the Malaysia Book of Records as the “Largest Range of Home-Grown Probiotic Products in Malaysia”. The recognition was presented to Pharm-D Health Science for developing more than 34 probiotic formulations catering to various health…

Pharm-D Health Science Unveils New Rare Disease Advocacy Program – JARANG & Collaborates with Hospital Kuala Lumpur & Rare Disease Patient Organizations Nationwide to Celebrate Rare Disease Day 2025

Dato’ Dr Mohd Azman bin Yacob (MOH Medical Development Division Director), Dr. Shamsul Anuar bin Kamarudin (Pengarah Hospital Tunku Azizah), Dr. Ngu Lock Hock (Head of Department of Genetics, Hospital Kuala Lumpur), Nadiah Hanim binti Abdul Latif (President of Malaysian Rare Disorders Society) and Mr. Wong Chin Cheang (Managing Director of Pharm-D Health Science) alongside…

冀公平分配医疗资源 罕见病患不再边缘化

你知道吗?根据吉隆坡中央医院(HKL)遗传学科的数据,截至去年1月,我国卫生部已收治1万3036名罕见疾病儿童。为提升公众对罕见疾病的认识,并为患者提供更多支持,HKL将于2月28日在医院礼堂举办罕见疾病日活动,与全球同步响应国际罕见疾病日。
本次活动将汇聚医疗专家、患者组织及社会各界人士,内容包括专题讲座、互动展示及趣味儿童活动,让参与者深入了解罕见疾病,并与专家交流。诚邀社会各界踊跃参与,共同关怀罕见病群体。

Asia IDDSI Festival 2024 Concluded Successfully with Healthcare & Culinary Experts to Promote Safe and Enjoyable Eating and Drinking for Dysphagia Individuals

The IDDSI Committee, joined by Chef Preston Walker (1st from left, 2nd row) and Chef James Ball of OHK (1st from right), as well as Ms. Jennifer Wu, representative of Pharm-D (2nd from right). The Asia IDDSI Festival 2024 concluded successfully on 29-30 Nov 2024 at @IMU University, Kuala Lumpur. Organised by the IDDSI Committee under…

Pharm-D and AGTC Genomics Join Forces to Enhance Accessibility of Healthcare Diagnostics and Precision Medicine in Malaysia

A new chapter in healthcare innovation unfolded today as Pharm-D Sdn Bhd joined forces with AGTC Genomics, a leading genomics center specialising in next-generation sequencing (NGS). Two companies formalised a strategic distributorship agreement, signaling a mutual commitment to enhance availability and accessibility of genetic screening to facilitate the advancement of precision medicine in Malaysia. This partnership aims to…

Pharm-D sets to be Secretariat of the Asia IDDSI Festival 2024

Kuala Lumpur – The Asia IDDSI Festival 2024 is set to take place this year on November 29-30 at IMU University, bringing together healthcare professionals, caregivers, culinary experts, and industry leaders to advance knowledge and practices in dysphagia care. Organised by the International Dysphagia Diet Standardisation Initiative IDDSI Committee, this year’s festival will see Pharm-D Sdn Bhd serving as the…

Pharm-D Health Science Marks a New Milestone in Healthcare Innovation through Biotenova-UPM Latest Research Partnership in Postbiotics

Kuala Lumpur, Malaysia – The Pharm-D Health Science group of companies, a leading player in the pharmaceutical and nutraceutical industry in Malaysia and Singapore, proudly announces its latest new milestone in its mission to push the boundaries of healthcare innovation, through its biotechnology research and development company Biotenova Sdn Bhd’s latest strategic research partnership with…